OCEAN BIOMEDICAL INC (OCEA) Stock Income Statement
NASDAQ:OCEA - Nasdaq - US67644C1045 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 3.27M | 10.21M | 2.48M | 570.00K | |||
| Research and Development | 331.00K | 709.00K | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 3.79M | 9.51M | N/A | N/A | |||
| Operating Income | -3.27M | -10.21M | -2.48M | -570.00K | |||
| Interest Income/Expense | -31.16M | -66.25M | 1.52M | 0.00 | |||
| Other Income/Expense | -518.00K | -22.93M | N/A | N/A | |||
| Non Recurring Items | N/A | -15.08M | N/A | N/A | |||
| Income Before Taxes | -35.18M | -114.47M | -960.00K | -560.00K | |||
| Net Income | -35.18M | -114.47M | -960.00K | -560.00K | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -1.30 | -4.35 | -0.07 | -0.04 | |||
| Statistics | |||||||
All data in USD